 JPMorgan Chase Co. lowered its holdings in Aimmune Therapeutics Inc NASDAQ:AIMT by 13.0 during the first quarter, according to its most recent disclosure with the Securities Exchange Commission. The firm owned 103,289 shares of the biotechnology companys stock after selling 15,411 shares during the quarter. JPMorgan Chase Co. owned 0.16 of Aimmune ... 